Rapt Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Rapt Therapeutics by Goldman Sachs Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $1.1M | 374k | 3.05 |
2024-03-31 | $1.7M | 186k | 8.98 |
2023-12-31 | $4.9M | 196k | 24.85 |
2023-09-30 | $3.0M | 178k | 16.62 |
2023-06-30 | $3.5M | 188k | 18.70 |
2023-03-31 | $3.2M | 174k | 18.35 |
2022-12-31 | $3.9M | 198k | 19.80 |
2022-06-30 | $511k | 28k | 18.27 |
2022-03-31 | $1.1M | 51k | 21.98 |
2021-12-31 | $1.3M | 36k | 36.74 |
2021-09-30 | $981k | 32k | 31.08 |
2021-03-31 | $227k | 10k | 22.16 |
2020-12-31 | $326k | 17k | 19.74 |
2020-06-30 | $2.6M | 88k | 29.02 |